(Q40606194)

22 September 2017

title

Cytokine immuno-gene therapy for treatment of brain tumors (English)

1 reference

22 September 2017

0 references

Terry Lichtor

1

1 reference

22 September 2017

Roberta P Glick

series ordinal

2

1 reference

22 September 2017

publication date

1 December 2003

1 reference

Journal of Neuro-Oncology

22 September 2017

published in

1 reference

22 September 2017

volume

65

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

247-259

1 reference

https://scigraph.springernature.com/pub.10.1023/b:neon.0000003654.83272.4a

22 September 2017

exact match

0 references

cites work

A pilot study of intralymphatic interleukin-2. II. Clinical and biological effects

1 reference

12 December 2020

Interleukin-2 gene therapy in a patient with glioblastoma

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity

1 reference

12 December 2020

Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigens

1 reference

12 December 2020

Lymphokines and cytokines as cancer treatment. Immunotherapy realized

1 reference

12 December 2020

Intra-lymphatic administration of interleukin-2 (IL-2) in cancer patients: a pilot study

1 reference

12 December 2020

A randomized double-blinded comparison of the antiemetic efficacy of ondansetron and droperidol in patients receiving high-dose interleukin-2.

1 reference

12 December 2020

Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma

1 reference

12 December 2020

Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma

1 reference

12 December 2020

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

12 December 2020

Survival and toxicity of an allogeneic cytokine-secreting fibroblast vaccine in the central nervous system

1 reference

12 December 2020

A new dominant hybrid selective marker for higher eukaryotic cells

1 reference

12 December 2020

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

12 December 2020

Treatment of glioma by engineered interleukin 4-secreting cells.

1 reference

12 December 2020

Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.

1 reference

12 December 2020

Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.

1 reference

12 December 2020

National survey of patterns of care for brain-tumor patients

1 reference

12 December 2020

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

1 reference

12 December 2020

Hypoprothrombinemia associated with interleukin-2 therapy: correction with vitamin K

1 reference

12 December 2020

The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma

1 reference

12 December 2020

Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity

1 reference

12 December 2020

Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice

1 reference

12 December 2020

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

1 reference

12 December 2020

Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse

1 reference

12 December 2020

Hematopoietic growth factors: biology and clinical application

1 reference

12 December 2020

RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.

1 reference

12 December 2020

Dendritic Cells Pulsed with a Tumor-specific Peptide Induce Long-lasting Immunity and Are Effective against Murine Intracerebral Melanoma

1 reference

12 December 2020

Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity

1 reference

12 December 2020

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

1 reference

12 December 2020

Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.

1 reference

12 December 2020

Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells

1 reference

12 December 2020

Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo

1 reference

12 December 2020

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion

1 reference

12 December 2020

Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response

1 reference

12 December 2020

Cytokines: structure, function and synthesis.

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

12 December 2020

Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice

1 reference

12 December 2020

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

12 December 2020

A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus

1 reference

12 December 2020

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

12 December 2020

10.1023/B:NEON.0000003654.83272.4A

Identifiers

DOI

1 reference

Dimensions Publication ID

22 September 2017

1002031209

0 references

1 reference